Hot Features
Premium
Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 572,355 |
|
|||||
| News | - | ||||||
| Day High | 0.7674 | Low High |
|||||
| Day Low | 0.721 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| AlloVir Inc | ALVR | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.022 | 2.99% | 0.7569 | 17:08:56 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.731 | 0.721 | 0.7674 | 0.7569 | 0.7349 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,139 | 572,355 | US$ 0.747444 | US$ 427,803 | - | 0.6231 - 6.12 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:39:48 | 7 | US$ 0.7425 | USD |
AlloVir Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 85.55M | 114.06M | - | 0 | -190.42M | -1.67 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
AlloVir News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ALVR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.74 | 0.78 | 0.72 | 0.7518406 | 376,759 | 0.0169 | 2.28% |
| 1 Month | 0.744 | 0.85 | 0.7057 | 0.7686728 | 647,527 | 0.0129 | 1.73% |
| 3 Months | 0.67 | 0.85 | 0.642 | 0.7231699 | 788,530 | 0.0869 | 12.97% |
| 6 Months | 1.72 | 2.485 | 0.6231 | 0.9616759 | 1,420,811 | -0.9631 | -55.99% |
| 1 Year | 3.86 | 6.12 | 0.6231 | 1.68 | 1,055,427 | -3.10 | -80.39% |
| 3 Years | 22.08 | 26.41 | 0.6231 | 4.99 | 673,945 | -21.32 | -96.57% |
| 5 Years | 22.82 | 48.96 | 0.6231 | 7.93 | 610,550 | -22.06 | -96.68% |
AlloVir Description
| AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting five viruses namely BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6. |
